|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 4/22/24 TRxADE HEALTH, Inc. 10-K 12/31/23 94:12M M2 Compliance LLC/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 2.09M
2: EX-19.1 Report Furnished to Security Holders HTML 24K
3: EX-21.1 Subsidiaries List HTML 23K
4: EX-23.1 Consent of Expert or Counsel HTML 23K
5: EX-23.2 Consent of Expert or Counsel HTML 23K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 28K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 28K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 24K
15: R1 Cover HTML 99K
16: R2 Consolidated Balance Sheets HTML 157K
17: R3 Consolidated Balance Sheets (Parenthetical) HTML 50K
18: R4 Consolidated Statements of Operations HTML 155K
19: R5 Consolidated Statements of Changes in HTML 94K
Stockholders' Equity
20: R6 Consolidated Statements of Cash Flows HTML 145K
21: R7 Pay vs Performance Disclosure HTML 36K
22: R8 Insider Trading Arrangements HTML 30K
23: R9 Organization and Basis of Presentation HTML 99K
24: R10 Going Concern HTML 29K
25: R11 Acquisitions and Dispositions HTML 120K
26: R12 Related Party Transactions HTML 38K
27: R13 Revenue Recognition HTML 42K
28: R14 Inventory HTML 30K
29: R15 Notes Receivable HTML 28K
30: R16 Intangible Assets HTML 34K
31: R17 Other Current Liabilities HTML 31K
32: R18 Contingent Funding Liabilities HTML 46K
33: R19 Notes Payable HTML 92K
34: R20 Income Taxes HTML 81K
35: R21 Stockholders? Equity HTML 46K
36: R22 Prefunded and Private Placement Warrants HTML 31K
37: R23 Warrants HTML 57K
38: R24 Options HTML 71K
39: R25 Contingencies HTML 41K
40: R26 Leases HTML 53K
41: R27 Segment Reporting HTML 51K
42: R28 Subsequent Events HTML 37K
43: R29 Organization and Basis of Presentation (Tables) HTML 40K
44: R30 Acquisitions and Dispositions (Tables) HTML 106K
45: R31 Revenue Recognition (Tables) HTML 35K
46: R32 Inventory (Tables) HTML 30K
47: R33 Intangible Assets (Tables) HTML 34K
48: R34 Other Current Liabilities (Tables) HTML 29K
49: R35 Notes Payable (Tables) HTML 44K
50: R36 Income Taxes (Tables) HTML 81K
51: R37 Warrants (Tables) HTML 55K
52: R38 Options (Tables) HTML 62K
53: R39 Leases (Tables) HTML 47K
54: R40 Segment Reporting (Tables) HTML 43K
55: R41 Schedule of Basic and Dilutive Income (Loss) Per HTML 101K
Share (Details)
56: R42 Organization and Basis of Presentation (Details HTML 151K
Narrative)
57: R43 Going Concern (Details Narrative) HTML 33K
58: R44 Schedule of Purchase Price Allocation (Details) HTML 62K
59: R45 Schedule of Fair Values of Assets Acquired HTML 37K
(Details)
60: R46 Schedule of Financial Statements of Discontinued HTML 46K
Operations (Details)
61: R47 Schedule of Assets and Liabilities (Details) HTML 59K
62: R48 Schedule of Discontinued Operations (Details) HTML 76K
63: R49 Acquisitions and Dispositions (Details Narrative) HTML 78K
64: R50 Related Party Transactions (Details Narrative) HTML 57K
65: R51 Schedule of Disaggregated Revenue (Details) HTML 43K
66: R52 Schedule of Inventory (Details) HTML 30K
67: R53 Notes Receivable (Details Narrative) HTML 32K
68: R54 Schedule of Intangible Assets Net (Details) HTML 41K
69: R55 Schedule of Other Current Liabilities (Details) HTML 31K
70: R56 Contingent Funding Liabilities (Details Narrative) HTML 46K
71: R57 Schedule of Notes Payable Balances (Details) HTML 81K
72: R58 Notes Payable (Details Narrative) HTML 175K
73: R59 Schedule of Provision for Income Taxes (Details) HTML 38K
74: R60 Schedule of Income (Loss) Before Income Taxes HTML 30K
(Details)
75: R61 Schedule of Deferred Tax Assets and Liabilities HTML 41K
(Details)
76: R62 Income Taxes (Details Narrative) HTML 25K
77: R63 Stockholders? Equity (Details Narrative) HTML 78K
78: R64 Prefunded and Private Placement Warrants (Details HTML 34K
Narrative)
79: R65 Summary of Assumptions Used to Estimate Fair Value HTML 37K
of Warrants Granted (Details)
80: R66 Schedule of Outstanding and Exercisable Warrants HTML 57K
(Details)
81: R67 Warrants (Details Narrative) HTML 41K
82: R68 Schedule of Stock Option Activity (Details) HTML 84K
83: R69 Options (Details Narrative) HTML 59K
84: R70 Contingencies (Details Narrative) HTML 57K
85: R71 Schedule of Operating Leases (Details) HTML 42K
86: R72 Schedule of Future Minimum Payments for Operating HTML 54K
Lease Liabilities (Details)
87: R73 Leases (Details Narrative) HTML 41K
88: R74 Schedule of Business Interests Into Reportable HTML 77K
Segments (Details)
89: R75 Subsequent Events (Details Narrative) HTML 52K
91: XML IDEA XML File -- Filing Summary XML 160K
94: XML XBRL Instance -- form10-k_htm XML 1.78M
90: EXCEL IDEA Workbook of Financial Report Info XLSX 164K
11: EX-101.CAL XBRL Calculations -- meds-20231231_cal XML 251K
12: EX-101.DEF XBRL Definitions -- meds-20231231_def XML 744K
13: EX-101.LAB XBRL Labels -- meds-20231231_lab XML 1.57M
14: EX-101.PRE XBRL Presentations -- meds-20231231_pre XML 1.14M
10: EX-101.SCH XBRL Schema -- meds-20231231 XSD 227K
92: JSON XBRL Instance as JSON Data -- MetaLinks 555± 784K
93: ZIP XBRL Zipped Folder -- 0001493152-24-015595-xbrl Zip 427K
Exhibit 32.2
Certification of Chief Financial Officer
Pursuant to 18 U.S.C. Section 1350, As Adopted Pursuant to Section 906 of The Sarbanes-Oxley Act of 2002
I, Prashant Patel, certify, as of the date hereof, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of TRxADE HEALTH, INC. on Form 10-K for the fiscal year ended December 31, 2023 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Form 10-K fairly presents in all material respects the financial condition and results of operations of TRxADE HEALTH, INC. at the dates and for the periods indicated.
| Dated: April 22, 2024 | |
| /s/ Prashant Patel | |
| Prashant Patel | |
| Chief Financial Officer | |
| (Principal Financial/Accounting Officer) |
A signed original of this written statement required by Section 906 has been provided to TRxADE HEALTH, INC. and will be retained by TRxADE HEALTH, INC. and furnished to the Securities and Exchange Commission or its staff upon request.
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 4/22/24 | |||
| For Period end: | 12/31/23 | NT 10-K | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/03/24 TRxADE HEALTH, Inc. 10-K/A 12/31/23 13:798K M2 Compliance LLC/FA |